-
-
-
-
-
-
-
Vivendi to Convene a Shareholders’ Meeting on December 9, 2024, to Vote on the Split Project
-
-
-
-
-
-
-
Vivendi: Strong Growth in Results in 2023
-
-
-
-
-
-
-
Vivendi: Strong Growth of the Group’s Operating Activities and EBITA in 2022
-
-
-
-
-
-
-
Havas Group acquires Paris-based MedEd specialist Raison de Santé to Reinforce its Global Medical Education Offering within Havas Health & You
-
-
-
-
-
-
-
Vivendi: Very Good Results for the First Half of 2021
-
-
-
-
-
-
-
Vivendi: the Tencent-led Consortium Has Completed the Exercise of Its Call Option and Now Owns 20% of UMG’s share capital
-
-
-
-
-
-
-
Vivendi: Improved Revenue Growth in the Third Quarter Of 2020
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

